epitope mapping at the C-terminus of RFLAT-1 of human origin
recommended for detection of RFLAT-1 of mouse, rat and human origin by WB, IF and ELISA; also reactive with additional species, including canine, bovine and porcine
blocking peptide, sc-9606 P
TransCruz reagent for Gel Supershift and ChIP applications, sc-9606 X, 200 µg/0.1 ml
RFLAT-1 Background Information RANTES factor of late activated T lymphocytes-1 (RFLAT-1), also designated BTEB3 and Kruppel-like factor 13 (KLF13), is a novel transcription factor that is expressed in T cells in the late stages of activation. This delayed induction coincides with the expression of RANTES, a chemoattractant cytokine for monocytes, T lymphocytes, eosinophils, basophils and natural killer cells. RFLAT-1 is localized to the nucleus, where it associates with the A site of the RANTES promoter and, in turn, faciliates transcriptional activation. RFLAT-1 is related to the transcription factor TFIIA-like zinc finger protein superfamily, as it contains three distinct and contigous zinc finger motifs at the carboxy- terminus and a proline-rich transcriptional activation domain, which are also present in TFIIA family of proteins, including Sp1 and Sp3. Although RFLAT-1 activates gene-specific transcription in activated T cells, it is also ubiquitously expressed in various cell types where it is likely regulated by phosphorylation. Late stage transcriptional activation of RANTES in activated T cells is also strongly influenced by Rel proteins of the NF˚B family, suggesting that RFLAT-1 and Rel may synergistically activate the RANTES promoter.
RFLAT-1 (C-19) Product Citations
See how others have used RFLAT-1 (C-19): sc-9606 antibody and or RFLAT-1 (C-19) antibody conjugates.
